For more information or confidential assistance
800-306-3180
se habla español

Mother Demands Labeling Changes for Zofran

GlaxoSmithKline (GSK) is engaging in wrongful conduct by failing to adequately disclose the risks of Zofran when used by women who are pregnant, according to a new birth defect lawsuit filed by a mother from Tennessee. The lawsuit is pending in the U.S. District Court for the Eastern District of... Read more »

Plaintiff Argues Zofran Caused Son’s Heart Defect

pregnant woman wearing white in profile
A recent complaint was filed in the United States District Court for the District of Massachusetts, where it joins the Zofran (Ondansetron) Products Liability Litigation known as MDL 2657. The case centers upon allegations that drug maker GlaxoSmithKline (GSK) negligently marketed its powerful anti-nausea drug to pregnant women without providing... Read more »

Study Suggests Xarelto Presents Greater Risk for Kidney Patients

According to recently-released research findings, next-generation blood-thinning drug Xarelto may pose additional risk to patients who are already suffering from kidney disease. The study, based on data taken from the Department of Defense electronic medical records system, found that those with existing kidney ailments were significantly more likely to experience... Read more »

New Report Warns of 21st Century Cures Act Shortfalls

drugreporter.com
In December 2015, non-profit group Public Citizen published a report highlighting a provision in the proposed 21st Century Cures Act that could cost taxpayers $12 billion — and that’s just one of the expenses. The report — written by Sammy Almashat and Sarah Sorscher of Public Citizen’s Health Research Group... Read more »

FDA Approval of Xarelto May Have Been Based on False Data

xarelto pill bottle
Thousands of Xarelto users have brought federal lawsuits against the drug’s manufacturers alleging that the anticoagulant caused uncontrollable bleeding and severe injuries. Recent reports shed light on a how the drug made it to the market with FDA approval. The anticoagulant’s drug trial was based on what may have been a... Read more »